• Our Technology
    • AIM™ NT Platform
    • AIM™ ACT Adoptive Cellular Therapy
    • AIM™ INJ Direct Injection
    • Abstracts and Publications
  • Our Pipeline
    • Overview
  • Our Company
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Autoimmune and Infectious Diseases SAB
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • Email Alerts
    • Contact
  • >Newsroom
    • Latest News
    • Archives
    • Media Inquiries
  • >Careers
    • Careers
    • Job Opportunities
  • >Contact
    • General Inquiries
Search
NeximmuneNeximmune
  • Our Technology
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Our Pipeline
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Our Company
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Investors
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Our Technology
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Our Pipeline
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Our Company
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Investors
    • Our Technology
      • AIM™ NT Platform
      • AIM™ ACT Adoptive Cellular Therapy
      • AIM™ INJ Direct Injection
      • Abstracts and Publications
    • Our Pipeline
      • Overview
    • Our Company
      • Overview
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Autoimmune and Infectious Diseases SAB
    • Investors
      • Overview
      • Press Releases
      • Events and Presentations
      • Financials and Filings
      • Stock Information
      • Corporate Governance
      • Email Alerts
      • Contact
  • Our Technology
    • AIM™ NT Platform
    • AIM™ ACT Adoptive Cellular Therapy
    • AIM™ INJ Direct Injection
    • Abstracts and Publications
  • Our Pipeline
    • Overview
  • Our Company
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Autoimmune and Infectious Diseases SAB
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • Email Alerts
    • Contact
  • >Newsroom
    • Latest News
    • Archives
    • Media Inquiries
  • >Careers
    • Careers
    • Job Opportunities
  • >Contact
    • General Inquiries
Missionrajeshl2021-02-03T13:14:06-05:00

Mission:

[[Copy Here]]

  • Our Company
  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Autoimmune and Infectious Diseases SAB

[[Copy Here]]

  • Our Technology
  • AIM™ Nanoparticle Platform
  • AIM™ ACT Adoptive Cell Therapy
  • AIM™ INJ Direct Injection
  • Abstracts and Publications
  • Our Pipeline
  • Overview
  • Careers
  • Join Us
  • Our Company
  • Overview
  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Newsroom
  • Latest News
  • Archives
  • Media Inquiries
  • Contact
  • General Inquiries
  • Investors
  • Overview
  • Press Releases
  • Events and Presentations
  • Financials and Filings
  • Stock Information
  • Corporate Governance
  • Email Alerts
  • Contact
About Us

NexImmune is a rapidly growing leader in the emerging field of antigen-directed immunotherapies. We are developing a novel technology platform with broad application across multiple disease areas.

Our Vision is to conquer cancer and life-threatening immune-mediated conditions by directing natural, disease-specific immune responses.

NexImmune footer logo

9119 Gaither Road
Gaithersburg, MD 20877

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to NexImmune, its subsidiaries or affiliates. No use of any NexImmune trademark, trade name, or trade dress in this site may be made without the prior written authorization of NexImmune, except to identify the product or services of the company.

© NexImmune. All Rights Reserved. 2021

  • Terms of Use
  • Privacy
  • Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT